SynthesisCanadian respiratory journal

Transition from intravenous epoprostenol to oral or subcutaneous therapy in pulmonary arterial hypertension: a retrospective case series and systematic review.

Kirily Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.